BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 530945)

  • 1. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative cytologic diagnosis of medullary carcinoma of the thyroid].
    Rabitti C; Fadda G; Minimo C; Coronetta F; Russo RM; Capelli A
    Pathologica; 1989; 81(1072):171-7. PubMed ID: 2570396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
    Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
    Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
    Hamada S; Ishikawa N; Yoshi M; Morita R; Fukunaga M
    Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for the familial form of medullary cancer of the thyroid].
    Allannic H
    Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of tumor markers in monitoring thyroid carcinoma].
    Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF; Fritsche HA; Samaan NA
    J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary carcinoma of the thyroid gland: the complete syndrome in a child.
    Levin DL; Perlia C; Tashjian AH
    Pediatrics; 1973 Aug; 52(2):192-6. PubMed ID: 4721441
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of radioassays for calcitonin, CEA-S, AFP and ferritin as tumor markers (author's transl)].
    Morita R; Yoshii M
    Rinsho Hoshasen; 1979 Jul; 24(7):755-61. PubMed ID: 90180
    [No Abstract]   [Full Text] [Related]  

  • 16. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medullary carcinoma of the thyroid (author's transl)].
    Kiffner E; Beitinger M; Löhrs U; Spelsberg F
    Med Klin; 1977 Dec; 72(49):2115-7. PubMed ID: 927309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembronic antigen and endocrine response in a patient with Sipple's syndrome following surgery.
    Nakada T; Shigematsu H; Nagayama T; Miyauchi T; Yoshida Y; Sakiyama S; Katayama T; Shimada F
    Endocrinol Jpn; 1981 Oct; 28(5):551-62. PubMed ID: 6284492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers].
    Brasanac D; Jancić-Zgurics M; Janković R; Tatić S
    Srp Arh Celok Lek; 1993; 121(3-7):70-3. PubMed ID: 7716641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
    degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
    Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.